Immediate Impact
4 standout
Citing Papers
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
2024 Standout
A guide to complement biology, pathology and therapeutic opportunity
2023 Standout
Works of Marcus Yountz being referenced
Long‐Term Safety and Efficacy of Eculizumab in Aquaporin‐4 IgG‐Positive NMOSD
2021
Consistent improvement with eculizumab across muscle groups in myasthenia gravis
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Marcus Yountz | 232 | 148 | 74 | 24 | 287 | |
| Clémence Boutière | 174 | 239 | 76 | 24 | 326 | |
| Kerri Prain | 234 | 95 | 35 | 16 | 313 | |
| Magd Zakaria | 83 | 221 | 35 | 27 | 285 | |
| Seyed Mohammad Baghbanian | 84 | 128 | 30 | 40 | 222 | |
| Elvira Sbragia | 80 | 190 | 34 | 25 | 244 | |
| P. Adam | 114 | 120 | 21 | 26 | 285 | |
| Andrew Swayne | 138 | 98 | 75 | 19 | 295 | |
| Christopher LaGanke | 78 | 188 | 65 | 28 | 280 | |
| Ratnakar Pingili | 73 | 146 | 72 | 15 | 178 | |
| Saskia Bresch | 115 | 88 | 24 | 21 | 229 |
All Works
Loading papers...